37263404|t|Nattokinase prevents beta-amyloid peptide (Abeta1-42) induced neuropsychiatric complications, neuroinflammation and BDNF signalling disruption in mice.
37263404|a|Alzheimer's disease (AD) is a chronic and progressive neurodegenerative disorder characterized by abnormal accumulation of extracellular beta-amyloid (Abeta) plaques and neuronal damage. Although AD is typically considered a cognitive neurodegenerative disorder, almost all people diagnosed with AD develop neuropsychiatric complications at some stage in their life span. The present study investigated the effect of chronic Nattokinase (NK) administration on beta-Amyloid peptide (Abeta1-42) induced neuropsychiatric conditions (depression-like behaviour, anxiety, and memory impairment) in mice. Abeta1-42 peptide injected mice demonstrated depression, anxiety, and impairment of cognitive abilities evaluated as increased immobility time in forced swim test (FST), decreased open arm time/entries in elevated plus maze (EPM) and reference and working memory error in radial arm maze (RAM) respectively with elevation in Interleukin-6 (IL-6), Tumour necrosis factor-alpha (TNF-alpha), reduction in Interleukin-10 (IL-10) and Brain-derived neurotrophic factor (BDNF) immunocontent within the hippocampus. Chronic administration of NK (50-100 mg/kg, i.p.) from day 8-27, prevented depression-like behaviour, anxiety, and memory impairment and normalized the neurochemical alteration within the hippocampus of mice injected with Abeta1-42 peptide. The effect of NK on psychiatric complications, learning, and memory was comparable to peripheral donepezil treatment. This study suggests that NK improves learning, memory impairment, and neuropsychiatric complications possibly through the downregulation of neuroinflammatory pathways and restoring BDNF signalling in AD.
37263404	62	92	neuropsychiatric complications	Disease	MESH:D008107
37263404	94	111	neuroinflammation	Disease	MESH:D000090862
37263404	116	120	BDNF	Gene	12064
37263404	146	150	mice	Species	10090
37263404	152	171	Alzheimer's disease	Disease	MESH:D000544
37263404	173	175	AD	Disease	MESH:D000544
37263404	206	232	neurodegenerative disorder	Disease	MESH:D019636
37263404	303	308	Abeta	Gene	351
37263404	322	337	neuronal damage	Disease	MESH:D009410
37263404	348	350	AD	Disease	MESH:D000544
37263404	377	413	cognitive neurodegenerative disorder	Disease	MESH:D019636
37263404	448	450	AD	Disease	MESH:D000544
37263404	459	489	neuropsychiatric complications	Disease	MESH:D008107
37263404	653	680	neuropsychiatric conditions	Disease	MESH:D001523
37263404	682	692	depression	Disease	MESH:D003866
37263404	709	716	anxiety	Disease	MESH:D001007
37263404	722	739	memory impairment	Disease	MESH:D008569
37263404	744	748	mice	Species	10090
37263404	777	781	mice	Species	10090
37263404	795	805	depression	Disease	MESH:D003866
37263404	807	814	anxiety	Disease	MESH:D001007
37263404	820	853	impairment of cognitive abilities	Disease	MESH:D003072
37263404	1075	1088	Interleukin-6	Gene	16193
37263404	1090	1094	IL-6	Gene	16193
37263404	1127	1136	TNF-alpha	Gene	21926
37263404	1152	1166	Interleukin-10	Gene	16153
37263404	1168	1173	IL-10	Gene	16153
37263404	1179	1212	Brain-derived neurotrophic factor	Gene	12064
37263404	1214	1218	BDNF	Gene	12064
37263404	1333	1343	depression	Disease	MESH:D003866
37263404	1360	1367	anxiety	Disease	MESH:D001007
37263404	1373	1390	memory impairment	Disease	MESH:D008569
37263404	1461	1465	mice	Species	10090
37263404	1519	1544	psychiatric complications	Disease	MESH:D001523
37263404	1596	1605	donepezil	Chemical	MESH:D000077265
37263404	1654	1681	learning, memory impairment	Disease	MESH:D007859
37263404	1687	1717	neuropsychiatric complications	Disease	MESH:D008107
37263404	1757	1774	neuroinflammatory	Disease	MESH:D000090862
37263404	1798	1802	BDNF	Gene	12064
37263404	1817	1819	AD	Disease	MESH:D000544
37263404	Association	MESH:D008107	12064
37263404	Association	MESH:D000544	12064
37263404	Association	MESH:D003866	16193
37263404	Negative_Correlation	MESH:D000077265	MESH:D001523

